| Dodd R Portman, Od, Inc | |
|
1190 Scott Blvd, Santa Clara, CA 95050-4562 | |
| (408) 241-3510 | |
| (408) 247-2605 |
| Full Name | Dodd R Portman, Od, Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1190 Scott Blvd, Santa Clara, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255544375 | NPI | - | NPPES |
| BI921 | Other | CA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 8010 TPL (California) | Primary |
| Provider Name | Dodd R Portman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1659341097 PECOS PAC ID: 8325032782 Enrollment ID: I20090223000072 |
News Archive
According to Prime Minister Theresa May, Artificial Intelligence (AI) is soon to change the scene in cancer and other disease diagnosis. She is to speak today in Macclesfield where she would acknowledge AI as a "new weapon" that is being used by the NHS and technology companies in research.
Image Movement of Montana (IMOM), a grassroots organization composed of 30 Montana healthcare facilities, announced today that three of its facilities have gone live with eMix after a successful beta test of the groundbreaking new technology. eMix (Electronic Medical Information Exchange) uses cloud computing to securely share radiology images and reports.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
When we train the reaching for and grasping of objects, we also train our brain. In other words, this action brings about changes in the connections of a certain neuronal population in the red nucleus, a region of the midbrain.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dodd R Portman, Od, Inc 1190 Scott Blvd, Santa Clara, CA 95050-4562 Ph: (408) 241-3510 | Dodd R Portman, Od, Inc 1190 Scott Blvd, Santa Clara, CA 95050-4562 Ph: (408) 241-3510 |
News Archive
According to Prime Minister Theresa May, Artificial Intelligence (AI) is soon to change the scene in cancer and other disease diagnosis. She is to speak today in Macclesfield where she would acknowledge AI as a "new weapon" that is being used by the NHS and technology companies in research.
Image Movement of Montana (IMOM), a grassroots organization composed of 30 Montana healthcare facilities, announced today that three of its facilities have gone live with eMix after a successful beta test of the groundbreaking new technology. eMix (Electronic Medical Information Exchange) uses cloud computing to securely share radiology images and reports.
VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
When we train the reaching for and grasping of objects, we also train our brain. In other words, this action brings about changes in the connections of a certain neuronal population in the red nucleus, a region of the midbrain.
› Verified 9 days ago
Dr. Jeffery Allen Calmere, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 770 Scott Blvd, Santa Clara, CA 95050 Phone: 408-296-0511 Fax: 408-296-1647 | |
Azinda Morrow, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 770 Scott Blvd, Santa Clara, CA 95050 Phone: 408-296-0511 Fax: 408-296-1647 | |
Nearsite Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5488 Marvell Ln, Santa Clara, CA 95054 Phone: 408-657-6327 | |
Noorie C Dong, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2817 El Camino Real, Santa Clara, CA 95051 Phone: 408-984-2020 Fax: 408-984-2016 | |
Steven Andrew Neunzig, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1190 Scott Blvd, Santa Clara, CA 95050 Phone: 408-241-3510 Fax: 408-247-2605 | |
Eyexam Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 2702 Augustine Dr Ste 120, Santa Clara, CA 95054 Phone: 408-528-7100 | |
Dr. Armando Amador Tapia, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-4205 |